Affichage 41 à 43 des 43 essais cliniques
1 | 2 | 3 | 4 | 5 |
1 |
2 |
3 |
4 |
5 |
1 | 2 | 3 | 4 | 5 |
|
ESSAIS CLINIQUES No essai ClinicalTrials.gov ID |
Phase | Coordonnateur(rice) | |
|---|---|---|---|
|
(EN) A Phase Ia/Ib, Open Label, Multicenter, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors
GO43860 NCT05581004  Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Ding Yuan Guo 514-340-8222 poste 24599 |
|
|
(EN) A Phase 2 Basket Study of the Oral TRK Inhibitor Larotrectinib in Subjects With NTRK Fusion-positive Tumors
NAVIGATE NCT02576431 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Sarah Kassis 514-340-8222 poste 22075 |
|
|
(EN) A Phase 1b Dose Escalation Study of BOLD-100 in Combination With FOLFOX Chemotherapy in Patients With Advanced Solid Tumours
BOLD-100-001 NCT04421820 Actif en recrutement
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS |
Angelica Lara 514-340-8222 poste 24624 |
Groupe d'étude en oncologie du Québec